Usefulness of the CADISS® System for the Cleavage of Severe Adhesions in Cholecystectomy

计划入组 15 人 · 首次发布于 2021 年 9 月 13 日

Acute Glycine Pharmacodynamic Study

计划入组 21 人 · 首次发布于 2012 年 6 月 1 日

Glycine Treatment of Prodromal Symptoms

计划入组 10 人 · 首次发布于 2005 年 12 月 22 日

Glycine(Aminosyn II 7 %, Sulfite-free, Aminosyn-PF 7%, Clinimix 2.75/5, Clinimix E 2.75/5, Clinisol 15, Freamine 6.9, Freamine III 10, Hepatamine 8, Olimel, Periolimel, Plenamine, Premasol, Primene, Procalamine 3, Prosol, Travasol 10, Trophamine 10 %)

<dd class="col-xl-8 col-md-9 col-sm-8">C₂H₅NO₂</dd>

oral glycine

Ferrous glycine sulfate

C₄H₁₀FeN₂O₈S

Ryder System

United States

GOSHEN HEALTH SYSTEM

United States

MEMORIAL HEALTHCARE SYSTEM

United States

Andelyn Biosciences Partners with Drake Rayden Foundation to Manufacture AAV Gene Therapy for Rare NKH Disease

Quantum-Si Advances Proteus Platform Development with Breakthrough Controlled Cleavage Chemistry for Protein Sequencing

DT-109: Novel Glycine-Based Compound Shows Dual Efficacy Against Atherosclerosis and MASH